Search research articles
Contact Us
Filters
Showing results (131-140 of 157) with videos related to
Page
of 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA
Jordi Remon, Benjamin Lacas, Roy Herbst, et al.
Blood Advances
|
July 22, 2018
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)
John C Byrd, Amy S Ruppert, Nyla A Heerema, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 30, 2007
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)
Elizabeth A Johnson, Randolph S Marks, Sumithra J Mandrekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012
Herbert H Pang, Xiaofei Wang, Thomas E Stinchcombe, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 25, 2012
Randomized phase II trial of sulindac for lung cancer chemoprevention
Paul J Limburg, Sumithra J Mandrekar, Marie Christine Aubry, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 19, 2022
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection
Jeffrey M Jacobson, David Zahrieh, Carrie A Strand, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 26, 2026
PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials
Allison Booth, Shauna Hillman, Kristina Laumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma
Martha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Matthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Blood Advances
|
December 21, 2018
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)
Gail J Roboz, Sumithra J Mandrekar, Pinkal Desai, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 157) with videos related to
Sort By:
Page
of 16
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA
Jordi Remon, Benjamin Lacas, Roy Herbst, et al.
Blood Advances
|
July 22, 2018
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)
John C Byrd, Amy S Ruppert, Nyla A Heerema, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 30, 2007
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)
Elizabeth A Johnson, Randolph S Marks, Sumithra J Mandrekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012
Herbert H Pang, Xiaofei Wang, Thomas E Stinchcombe, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 25, 2012
Randomized phase II trial of sulindac for lung cancer chemoprevention
Paul J Limburg, Sumithra J Mandrekar, Marie Christine Aubry, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
December 19, 2022
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection
Jeffrey M Jacobson, David Zahrieh, Carrie A Strand, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 26, 2026
PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials
Allison Booth, Shauna Hillman, Kristina Laumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma
Martha Q Lacy, Suzanne R Hayman, Morie A Gertz, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Matthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Blood Advances
|
December 21, 2018
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)
Gail J Roboz, Sumithra J Mandrekar, Pinkal Desai, et al.
Page
of 16